CTC
IBRX icon

Central Trust Company’s ImmunityBio IBRX Stock Holding History

Central Trust Company’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.67K Hold
1,000
– – ﹤0.01% 1201
2025
Q4 		$1.98K Hold
1,000
– – ﹤0.01% 1329
2025
Q3 		$2.46K Hold
1,000
– – ﹤0.01% 1272
2025
Q2 		$2.64K Hold
1,000
– – ﹤0.01% 1285
2025
Q1 		$3.01K Hold
1,000
– – ﹤0.01% 1279
2024
Q4 		$2.56K Hold
1,000
– – ﹤0.01% 1291
2024
Q3 		$3.72K Hold
1,000
– – ﹤0.01% 1195
2024
Q2 		$6.32K Hold
1,000
– – ﹤0.01% 1141
2024
Q1 		$5.37K Hold
1,000
– – ﹤0.01% 1164
2023
Q4 		$5.02K Buy
+1,000
New +$3.14K ﹤0.01% 1162

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return